NGN BioMed Opportunity II LP

NGN BioMed Opportunity II LP discloses dealings in Zenith Capital Corp. to SEDI. Between 26 April 2017 and 26 October 2020, the trades on record add up to 9 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 3 November 2020: a transaction of €84k, in Zenith Capital Corp. Typically, a trade is published a median of 4 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.